Table 5.
Association between Strongyloides stercoralis infection and each cancer type (patients born before 1960, N = 4,056)
| Stratified analysis | Multivariate analysis | ||||
|---|---|---|---|---|---|
| S. stercoralis infection rate | P value | OR | 95% CI | P value | |
| Control | 5.7% (147/2,596) | ||||
| Total cancer | 8.7% (117/1,352) | < 0.001* | 1.28 | 0.98–1.66 | 0.06‡ |
| Esophagus | 6.4% (7/109) | 0.48† | 0.65 | 0.29–1.45 | 0.29§ |
| Stomach | 9.9% (24/242) | 0.45† | 1.22 | 0.76–1.97 | 0.42§ |
| Biliary tract | 14.5% (10/69) | 0.05† | 1.90 | 0.93–3.87 | 0.08§ |
| Liver | 6.4% (9/140) | 0.43† | 0.72 | 0.35–1.47 | 0.37§ |
| Colon and rectum | 7.7% (15/194) | 0.68† | 0.94 | 0.53–1.66 | 0.82§ |
| Lung | 9.6% (40/418) | 0.46† | 1.09 | 0.73–1.64 | 0.68§ |
| Pancreas | 5.4% (2/37) | 0.77† | 0.83 | 0.19–3.55 | 0.80§ |
| Lymphoma without ATLL | 2.7% (1/37) | 0.37† | 0.28 | 0.28–2.08 | 0.21§ |
ATLL = adult T-cell leukemia/lymphoma; CI = confidence interval; OR = odds ratio.
A χ2 analysis was used to compare S. stercoralis infection between patients with cancer (total cancer) and control patients (control).
A χ2 analysis was used to compare S. stercoralis infection between patients with each type of cancer and patients with other types of cancer.
A logistic regression analysis, adjusted for age and sex, was used to compare S. stercoralis infection between patients with cancer (total cancer) and control patients (control).
A logistic regression analysis, adjusted for age and sex, was used to compare S. stercoralis infection between patients with each type of cancer and patients with other types of cancer.